novavax booster after pfizer

Try the tool that will help you invest smarter, faster, and better. Now, the company is mentioning certain risks that could impact its ability to survive. Alastair Grant, Associated Press. The results from two large phase 3 trials on Novavax have been published. Interpretation services are available if you need them. Unlike mRNA vaccines, such as Pfizer and Moderna, the Novavax vaccine uses a longer-standing protein-based technology. It's only for those either unable or unwilling to get the updated Omicron-specific mRNA bivalent booster. It's authorized as a two-dose primary series, with each dose typically given three weeks. And it can be given until at least six months after a primary series. An 8-week interval is recommended between primary series doses of NVX-CoV2373. The shot is given six months after the primary vaccine to adults only if they have not received any booster shot previously, and they cannot receive a Pfizer-BioNTech or Moderna mRNA bivalent booster for a medical or any other reason. Tech Stock In Buy Zone As It Joins Sector Leaders' Final Four, Novavax Jumps After Pledging To Update Its Covid Shot; Pfizer, Moderna Slip, Biotech Firestorm Takes Down Novavax Despite Quadrupled Sales, Why Novavax's Uphill Battle Continues Despite Winning U.S. However, protein subunit vaccines use a more conventional technology than mRNA vaccines, so more technicians are familiar with this approach, Kis said. But Covid vaccinations in the U.S. are waning. and Mexico trials used the same case definitions, and these consistent results, therefore, provide much confidence in the use of this vaccine for the global population. But the risks mentioned above could change that. And investors bet on the company's ability to bring its vaccine candidate to market. This study has five different arms and will test various types of Novavax boosters. Your immune system may not respond as strongly to the spike protein on its own. These include soreness around the site of injection, fatigue, headaches and muscle aches. Also, combinations of different Covid-19 vaccine technologies have a favourable safety profile, added Ghent University Faculty of Medicine & Health Science professor emeritus Geert Leroux-Roels. It's pure protein, there is no nucleic acid that is injected into your body. Serious adverse events after the booster dose were reported by 43/12,777 participants (0.3%). It's important to note Novavax uses a different means of vaccinating patients. 3/01/2023 Let's take a closer look. The cancellation means more than 141 million doses won't be bought by Japan. Novavax Booster Recommendation On the positive side, switching to Novavax as a booster is unlikely to offer lower protection compared with people who stuck with the same vaccine technology. . As remains the case with all COVID-19 vaccines, boosters will be administered without monetary cost to consumers. These reactions usually occur soon after youve had your vaccine, which is why you need to wait at least 15 minutes. According to Dr. Peter English, a retired consultant in communicable disease control, former editor of Vaccines in Practice, and immediate past chair of the BMA Public Health Medicine Committee: [t]he vaccine is a much more traditional sort of vaccine than the mRNA and vector vaccines currently in use. This is despite the companys booster positioning being a sound market tactic in certain countries, experts said. NVX-CoV2373 is in several trials investigating it as the second dose of a different vaccine technology (heterologous combination), as well as the third dose in people who have previously received an authorised vaccine (heterologous booster). A primary course is 2 doses, 3 weeks apart. That's after its COVID-19 vaccine program won a big investment from the U.S. government. Australian authorities expect those who haven't already got the jab to roll up their sleeves for Novavax due to its protein base. Can diet help improve depression symptoms? Select the filter 'Novavax ages 12+ only' under 'Vaccine type'. At the same time, Novavax's expenses have climbed due to. Total revenue rose 73% to $1.9 billion. Unlike the latest boosters from Pfizer-BioNTech and Moderna, which. As a result, the shares skyrocketed, gaining more than 2,700% in a year. Is Novavax stock a sell after the company says it Get instant access to exclusive stock lists, expert market analysis and powerful tools with 2 months of IBD Digital for only $20! It is to be administered at least six months after a person has completed a primary COVID-19 vaccine series. Novavaxs vaccine includes an adjuvant, which may have a different safety profile from other parts of NVX-CoV2373, said Center for Clinical Epidemiology and Population Health director Dr Edward Belongia. In interviews, Novavax CEO Stanley Erck has said the vaccines use as a booster might be its biggest market in the US. Novavax, Inc. NVAX shares are trading lower by 6.76% to $32.84 Wednesday afternoon in possible reaction to competitor Moderna Inc MRNA receiving FDA authorization for emergency use of its. You can also call Healthline on 0800 358 5453 anytime to get advice. In an open-label continuation of the phase 3 randomized controlled trial among persons ages 18 years and older in the United States and Mexico, 12,777 participants received booster doses as of the data cut off (March 26, 2022). After injection, the nanoparticles are taken up . Thank you for taking the time to confirm your preferences. The flu vaccine and the hepatitis B vaccine, which doctors have administered throughout the U.S. since 1986, use this technology. 1 https://covid.cdc.gov/covid-data-tracker/#trends_dailycases It also contains a substance called an 'adjuvant' that strengthens the body's immune response to this protein. A first booster dose is recommended 4-6 months after the completion of the primary series. Today, Novavax's vaccine may be used as a booster. Saving Lives, Protecting People, Advisory Committee on Immunization Practices (ACIP), https://covid.cdc.gov/covid-data-tracker/#trends_dailycases, https://covid.cdc.gov/covid-data-tracker/#trends_dailydeaths_select_00, https://covid.cdc.gov/covid-data-tracker/#vaccine-effectiveness, https://covid.cdc.gov/covid-data-tracker/#vaccinations_vacc-people-additional-dose-totalpop, National Center for Immunization and Respiratory Diseases, Role of the ACIP in CDCs Vaccine Recommendations, Shared Clinical Decision-Making Recommendations, U.S. Department of Health & Human Services. And any good news could significantly lift the stock. 1. Hiring activity related to artificial intelligence increased by 7% in the pharmaceutical industry in Q3 2022, Whos hiring who? It won regulatory authorization a year after rivals, so it missed out on the initial big wave of demand and sales. In this Snapshot, we take a closer look at the potential side effects associated with the Oxford-AstraZeneca COVID-19 vaccine, also known as Vaxzevria. Novavax also lost $2.28 per share, narrowing from an $11.18 per-share loss in the year-ago period, but missing projections for a per-share loss of $1.01, according to FactSet. Immunoglobulin G (IgG) antibody responses against BA.1 and prototype strains showed similar responses across the three vaccine groups. Most side effects are mild and goaway within a few days. 'So what goes into you is a bit more complex because it includes a protein,' she added. The maker of the only traditional COVID-19 vaccine still widely available in the United States is raising doubts about its ability to stay in business. In response, NVAX stock plummeted 25.9% to close at 6.86 on today's stock market. Any side effects from the vaccine were largely mild to moderate and transient. At the same time, Novavax's expenses have climbed due to the costs of . The company indicates its supply lines. The latest experiments suggest that Pfizer's bivalent booster probably won't keep . We now await the peer-reviewed publication. The Pfizer vaccine remains the preferred COVID-19 vaccine for use in New Zealand, reflecting its excellent safety and effectiveness profile. Summary. According to the FDA, the Novavax booster vaccine is approved for people 18 years of age and older who are six months out from their first two COVID shots. Novavax would diversify vaccine options and potentially fill supply gaps. These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. Moderna and Pfizer's shots use mRNA technology that uses nucleic acid to generate a spike protein that imitates that of what the. Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data. Additionally, vaccination intentions were significantly higher among men (21.9%) than among women (11.9%). Children are less likely to have these sorts of side effects but may not volunteer symptoms. The Novavax is a protein based shot, unlike previous shots. We are no longer accepting comments on this article. In Europe, however, heterologous vaccine approaches are accepted to reduce side effect risk. Novavax's initial two-dose shots have been available since the summer. Vaccinations are slowing and the public health emergency in the U.S. is now slated to end in May. Why Novavax Stock Was Down in the Dumps This Week, 2 Beaten-Down Stocks That Might Be too Cheap to Ignore, More Likely to 5x First: Novavax vs. Ocugen, 2 Reasons to Avoid a Roth 401(k) for Your Retirement Savings, Want $1 Million in Retirement? How Viagra became a new 'tool' for young men, Ankylosing Spondylitis Pain: Fact or Fiction. Novavax differs from mRNA vaccines like Pfizer and Moderna but all have similar side effects after a person is jabbed. One such vaccine is Novavax. Is the intervention feasible to implement? As with any vaccine, you may have some temporary side effects after receiving Novavax. *Real-time prices by Nasdaq Last Sale. Preliminary Phase II data showed that a single booster of NVX-CoV2373 given six months after an initial two-dose regimen of the same vaccine led to a 4.6-fold increase in antibody titers. That would be in line with Pfizer's and Moderna's expectations. Novavax was part of Operation Warp Speed, but what took it so long to come online? Injection-site tenderness and pain, fatigue, headache, and muscle pain were the most reported adverse events. As Alex is jailed for horrific executions of his wife and son rumors abound in the sleepy South Carolina town of Walterboro - and locals say 'most people don't believe he is the killer'. 'Here We Go Again': Seagen Soars As Pfizer Reportedly Mulls A Takeover, Reata Stock Plummets As Official's Exit Shakes Up FDA's Neuroscience Unit, Looking For The Next Big Stock Market Winners? Hard data and deep insights on clinical trials strategy & operations, Specialty drug launch strategy and operations, The next chapter of clinical trial services, Trusted clinical trial packaging services, New hopes for advanced HCC patients, but the landscape is still lacking, Nubeqa approval to boost Bayers presence in prostate cancer market in Japan, Koneksa, SSI Strategy expand partnership for biomarker adoption in trials, US FDA clears Intellias IND to start hereditary angioedema therapy trial, Sanofis clinical trial of haemophilia A therapy in children meets endpoint, Iterative Health and FRI partner to introduce AIR technology in Florida, US, Quantum medicine: How quantum computers could change drug development, Whos hiring who? Novavax, which has a $17.16bn market cap, did not respond to a comment request. Therefore, while the Work Group reviewed data to support the recommendation, they did not determine their judgement for any of the domains listed below: Recommendations for adults who are not moderately or severely immunocompromised are shown below by primary series and includes 2-dose Moderna, Novavax, and Pfizer series in the first row and Janssen single-dose primary series in the second row. Novavax, in use in the U.S. since mid-2022, warned it may not survive in its latest earnings report, released after the market closed on Tuesday, CNN reported. If you select Novavax, the site will show a list of vaccination centres where Novavax can be given. News reports show Novavaxs delayed progress in securing authorisation is due to the limited resources available to make NVX-CoV2373. The company is discussing potential solutions with the government. But to reach success with that potential product, Novavax must have the financial strength to survive. The efficacy of Novavax against virus variants is unknown at this time. Novavax can also be used as a booster dose in people aged 18 years and older. In this Snapshot feature, we provide an overview of the Covaxin inactivated virus vaccine for COVID-19 and its possible side effects. A UK phase 2 trial shows that different COVID-19 booster shots are safe and boost immunity when given 10 to 12 weeks after two doses of the AstraZeneca/Oxford or Pfizer/BioNTech vaccines, although immune responses varied widely.. During the early days of the pandemic, Novavax (NVAX 10.97%) jumped into the spotlight. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests. If you feel unwell or are worried about any side effects, speak with your trusted health professional. The stock fell as . Pseudoneutralization responses against BA.5 for the prototype vaccine were comparable to those induced by the more closely matched BA.1 vaccine and bivalent vaccine candidates. 'The TGA and ATAGI continue to review emerging evidence on all COVID-19 vaccines.'. This Snapshot feature outlines the known side effects of CoronaVac, the COVID-19 vaccine developed by Chinese biotechnology company Sinovac. Unable to receive an mRNA vaccine (i.e., contraindicated or in the absence of all supply), Unwilling to receive an mRNA vaccine and would otherwise remain unvaccinated, Without history of prior COVID-19 booster receipt, Novavax phase III randomized controlled trial, unpublished data from manufacturer, CDC and University of Iowa/RAND survey, unpublished. Pfizer vaccine for COVID-19: What are the side effects? CombiVacS also found a higher immune response from AZ followed by . The vaccination involves injecting the nanoparticles into arm muscles alongside a compound extracted from the soapbark tree, which acts as an adjuvant to attract immune cells to the injection site. According to Prof. Paul Heath, professor of paediatric infectious diseases and director of the Vaccine Institute, St Georges, University of London and St Georges Hospital, London, and chief investigator of the Novavax United Kingdom trial:The results are very reassuring and importantly show that this vaccine appears to be safe and effective in populations from a range of communities and demographic groups, and those with a range of underlying comorbidities, now (across both trials) with a total number of participants of more than 45,000.. Novavax in March 2020 reported favourable safety data from its Phase III Nanoflu trial in adults aged 65 years and over. Adria Cimino has no position in any of the stocks mentioned. She also points out that, because the booster wanes after four to six months, you're likely to have fewer . Additionally, Novavax booster doses are of exactly the same formulation and dose as primary series doses, which means there is no learning curve for providers. Novavax was the first protein-based COVID vaccine to have been approved in Australia. The data demonstrate that the. But here, too, Novavax won regulatory nods after rivals Pfizer and Moderna. Novavaxs vaccine as a heterologous booster would be more appealing for policy makers if it were a tweaked version against more pressing variants of concern, added Leroux-Roels, who is an investigator in J&Js two-dose Covid-19 vaccine trial. The Motley Fool has positions in and recommends Pfizer. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. Early studies indicate that it may have similar efficacy to the Pfizer and Moderna vaccines but fewer side effects. The Novavax Covid-19 vaccine, which goes by the Scrabble-friendly trade name "Nuvaxovid," has been authorized as a two-dose primary series given three weeks. If you are unsure about your symptoms or if they get worse, call Healthline on0800 358 5453. Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. If youre unable to book online, you can call the COVID Vaccination Healthline on 0800 28 29 26 (8am to 8pm, 7 days a week). The Pfizer COVID-19 vaccine is the preferred option for someone who is pregnant, trying to get pregnant, or breastfeeding. Despite attempts at diversity, Covid-19 vaccine trials may still not represent the wider population, added Upstate Medical University Department of Microbiology and Immunology interim chair Dr Stephen Thomas. 'Whereas with the other vaccines, it's actually getting our cells to produce the protein and then your immune system sees it and reacts to it. Novavax is currently marketing two versions of NVX-CoV2373 one in partnership with . 2 It is also available as a booster at least 6 months after completing the primary course for any of the COVID-19 vaccines available in New Zealand. The vaccine has been proven to have 90 per cent efficacy rate against mild, moderate and severe disease, WHO said. What happens with U.S. funding and the Gavi dispute could help determine whether the company survives. If you're a shareholder, you might consider holding instead of selling at a loss. The federal government has acquired 51 million doses of Novavax as part of the vaccine rollout. Novavax has a version of its vaccine specific for the Beta variant of concern in preclinical investigations. The information has been obtained from sources we believe to be reliable; however no guarantee is made or implied with respect to its accuracy, timeliness, or completeness. U.S. regulators on Wednesday authorized a booster dose of the COVID-19 vaccine made by Novavax. How substantial are the undesirable anticipated effects? U.S. regulators on Wednesday authorized a booster dose of the COVID-19 vaccine made by Novavax. However, the risk for severe illness from COVID-19 is higher in people aged 65 years, those living in long-term care facilities, and those with chronic medical conditions. Novavax is a protein subunit vaccine. It's recommended that you do not have Novavax if you have had a severe allergic reaction (e.g. Is it time to give up on this embattled stock? | Novavax has secured FDA emergency authorization for its COVID-19 booster, seven weeks after Moderna and Pfizer-BioNTech scored . Novavax currently sells just one drug, the Covid vaccine. Does the target population feel that the desirable effects are large relative to undesirable effects? In recent times, headwinds have multiplied. A booster dose of NVX-CoV2373 is currently authorized for use in adults in Australia, Japan and New Zealand. Before the announcement late Tuesday, shares gained 6.8%. Ownership data provided by Refinitiv and Estimates data provided by FactSet. The Food and Drug . CDC Allows Novavax Monovalent COVID-19 Boosters for Adults Ages 18 and Older Media Statement For Immediate Release: Wednesday, October 19, 2022 Contact: Media Relations (404) 639-3286 Today, CDC's Director Rochelle P. Walensky, M.D., M.P.H., signed a decision memo allowing Novavax monovalent COVID-19 boosters for adults. In fact, NVX-CoV2373 as a heterologous booster could circumvent rare side effect issues that may arise from sticking with an mRNA vaccine as a third dose, noted Thomas, a Phase III Comirnaty investigator. However, 298 participants provided immunogenicity data and the data suggest that receipt of a Novavax booster dose induces enhanced immune response to both ancestral strain (geometric mean fold rise [GMFR]: 3.4 [95% CI: 2.8, 4.0) and to Omicron BA.1 (geometric mean fold rise [GMFR]: 17.3 [95% CI: 10.6, 28.1) when compared with the Novavax primary series. You can review and change the way we collect information below. As of October 6, 2022, 32,992 doses have been administered since primary series authorization in July 2022. Novavax's revenue climbed last year for one simple reason. You can get a prescription at the vaccinating Novavax clinic or prior to your appointment with your preferred GP. Is NVAX stock a 3/01/2023 The Pfizer vaccine remains the preferred COVID-19 vaccine for use in New Zealand, reflecting its excellent safety and effectiveness profile. 2022 Benzinga.com. Get market updates, educational videos, webinars, and stock analysis. SAGE recommends the use of the Novavax (NVX-CoV2373) vaccine as 2 doses (0.5 ml) given intramuscularly. They help us to know which pages are the most and least popular and see how visitors move around the site. Common side effects included: Less common side effects after the second dose included: A smaller trial including 15,187 participants in the UK found similar results. What is the latest research on the form of cancer Jimmy Carter has? anaphylaxis). You will need to agree to be vaccinated. No deaths occurred related to the booster dose. On January 31, 2022, Novavax submitted a request to the Food and Drug Administration (FDA) for emergency use authorization for its COVID-19 vaccine candidate. The Novavax vaccine has been thoroughly assessed for safety by our own Medsafe experts. The main reported rare but serious side effect after Novavax is severe allergic reaction (e.g. Information about the Novavax (Nuvaxovid) COVID-19 vaccine, including how to book, potential side effects, and who is eligible. Dec 21 (Reuters) - Novavax said on Tuesday the World Health Organization's (WHO) panel of experts had recommended a third dose of its vaccine, NVX-CoV2373, for immunocompromised persons. At the same time, Novavax's expenses have climbed due to the costs of commercializing the vaccine. The views expressed in the contents above are those of our users and do not necessarily reflect the views of MailOnline. The challenge with mRNA vaccine manufacturing is the necessary upskilling of existing technicians, who are in worldwide shortage, as well as mRNA vaccine manufacturing infrastructure, he added. Most people who wanted a primary series already got it, resulting in a decline in demand and less need for Novavax's product. Even though NVX-CoV2373s trials recruited thousands of participants, the rare side effects seen with mRNA and adenovirus-vectored Covid-19 vaccines only surfaced once millions of people were vaccinated, and this could also be the case with NVX-CoV2373, added Midwest Biomedical Research chief scientist Dr Kevin Maki. Oxford-AstraZeneca vaccine: What to know about side effects. The vaccine, which is the fifth to be approved in Australia, is able to be stored in a normal fridge for up to three months, unlike other doses which must be kept at very low temperatures. Booster Authorization, Here Are Novavax's U.S. Vaccination Numbers And They're Bleak, Dow Jones Tests Key Level; Health Care Stocks Tumble; 2 Types of Bears And One History Lesson, The Covid Gambit: Pfizer, Moderna Struggle To Get The Jump On Covid, Novavax Stock Plummets As 'Market Dynamics' Crush Its 2022 Sales Outlook, Stock Market Drops On Slumping Productivity; Energy Stocks Gain As Russia Throttles Pipeline. Pfizer and Moderna's. The CDC recommends people 12 and older who got the Novavax vaccine receive an age-appropriate, updated mRNA booster dose if at least 2 months have passed since their primary series or since their most recent booster dose. The Novavax is a protein based shot, unlike previous shots. The proteins inside the Novavax vaccine mimic COVID-19s spike protein. You can get your second dose of Novavax 3 weeks later. Hiring activity related to social responsibility increased by 10% in the pharmaceutical industry in Q3 2022, Whos hiring who? Cost basis and return based on previous market day close. Therefore, they recommend that pregnant people receive information about the risks of COVID-19 during pregnancy, the potential benefits of vaccination, and safety data limitations so that they can make their own decision. It depends on your tolerance for risk and whether you already own the shares. Further trials and analyses of the initial results are underway to understand its effects better. Today, Novavax's vaccine may be used as a booster. To manufacture protein subunit vaccines, insect cells are grown in large volumes over several weeks, and then infected with baculoviruses that contain the genetic code for the spike protein, Kis explained. We take your privacy seriously. Novavax Inc.'s shares plunged to a three-year low on Wednesday, a day after the COVID-19 vaccine maker raised doubts about its ability to remain in business.. Using NVX-CoV2373 as a heterologous booster is unlikely to reduce efficacy compared with sticking to the same vaccine technology, experts agreed. Is the ketogenic diet right for autoimmune conditions? You will be subject to the destination website's privacy policy when you follow the link. Additionally, there is a disproportionate burden of COVID-19 infections and deaths among racial and ethnic minority communities. Novavax's COVID-19 vaccine is for people age 12 and older who haven't received any COVID-19 vaccine yet. This vaccine contains fragments of the coronavirus spike protein that have been engineered in a laboratory. On Tuesday, the Centers for Disease Control and Prevention (CDC) endorsed the Food and Drug Administration's emergency approval of Novavax, a new COVID-19 vaccine that used a more old-fashioned method in its development, one that might be embraced by anyone leery of the Pfizer and Moderna mRNA vaccines. On a new IBD podcast, Jon Najarian explains 0DTE options and their unintended impact. Learn more about COVID-19 vaccine side effects. Currently, people are encouraged to stick with the same vaccine technology, even if it may mean waiting for several weeks for subsequent doses, said Edward Dougherty, a principal at his eponymous Washington DC-based healthcare consulting firm. They were created in moth cells and then assembled into nanoparticles small particles made of a few hundred atoms. That said, it is still unclear if using a different vaccine technology as a booster would improve efficacy as there is little data supporting that, noted Goepfert, a Phase III single-dose JNJ-78436735 investigator. In comparison, mRNA vaccine manufacturing is speedier and doesnt require such cells, since they are synthetically processed. mRNA and adenovirus-vectored vaccines do not require adjuvants. It uses a different technology. Start With These 3 Steps, Find The Best Long-Term Investments With IBD Long-Term Leaders, Run Custom Stock Screens With MarketSmith. By Andrew Brown For Australian Associated Press, Published: 17:39 EST, 2 March 2022 | Updated: 18:15 EST, 2 March 2022. The Novavax is a protein based shot, unlike previous shots. All rights reserved. Once again, the adult recommendation has not changed. The company ended its purchase agreement with Gavi, saying the organization failed to order the agreed upon number of vaccine doses last year. While they share COVID-19s molecular structure, they do not replicate or cause COVID-19. Rare occurrences of myocarditis or pericarditis were identified in primary series clinical trials and in global post marketing data preceding primary series authorization in the United States. '(Novavax) is doing that bit of work up front, before it's injected.'. Local and systemic reactogenicity appeared to be slightly more common after the booster dose than after dose 2, with severe (grade 3) systemic reactions reported in 23.2% and 15.1% of participants, respectively. The FDA specifically authorized the Novavax Covid-19 vaccine, adjuvanted, as "a first booster dose (0.5 mL) to the following individuals at least 6 months after completion of primary. Sinopharm COVID-19 vaccine: Should you worry about the side effects? Nearly everyone 6 months and older needs an updated ( bivalent) vaccine to stay up to date with COVID-19 vaccines. It's free. However, if adults who are not moderately or severely immunocompromised are unable or unwilling to get a bivalent mRNA booster, a monovalent Novavax booster dose is recommended at least 6 months after the primary series only without receipt of a previous booster(s). Novavax second boosters are available for eligible people aged 18 or older, 6 months after your first booster. "The U.S. now has access to the Novavax COVID-19 Vaccine, Adjuvanted, the first protein-based option, as a booster," Novavax President and CEO Stanley Erck said in a news release Wednesday . So, should you give up on Novavax? The company is studying a promising combined flu/coronavirus candidate in phase 2 trials. Epidemiologist Catherine Bennett told Daily Mail Australia Novavax was more of a 'conventional' approach to vaccines as the receiver was being injected with a protein.

Brian Jennings Obituary, Gadsden County Jail View, Durospan Steel Buildings Ebay, Articles N